We just mentioned at BRCAscoop that a new paper in Genome Research from Helicos reports a new single molecule sequencing strategy for the BRCA1 gene that is discussed in a way that could leave one wondering whether they think they have a workaround for existing intellectual property. It may be important that their single molecule sequencing method does not involve any DNA amplification.
As I am not a lawyer, I'm curious to see what folks with expertise in IP law will think about this.


Comments